BioNTech tells Euronews it will seek EU approval to use its COVID vaccine in children aged 12 to 15
BioNTech/Pfizer said in March that its vaccine has proven to be 100% effective in youngsters aged 12 to 15.
Full Article
BioNTech tells Euronews it will seek EU approval to use its COVID vaccine in children aged 12 to 15
euronews
0 shares
1 views
- More about:
BioNTech- Pfizer
- Euronews
- European Union
You might like
Related news coverage
The Latest: US to limit travel from India starting Tuesday
SeattlePI.com
The U.S. will restrict travel from India starting on May 4, the White House said Friday, citing a devastating rise in COVID-19..
Advertisement
More coverage
Pfizer Seeking FDA Approval For Vaccinating Children 12-15
Newsy
Watch VideoPfizer and BioNTech are asking the FDA to approve the use of its COVID vaccine for kids 12 to 15.
Last week,..